dapagliflozin/metformin (HCP1801) / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dapagliflozin/metformin (HCP1801) / Hanmi
NCT03826641: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

Completed
1
85
RoW
HCP1805, HCP1801
Hanmi Pharmaceutical Company Limited
Healthy
03/19
04/19

Download Options